Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Curr HIV/AIDS Rep. 2020 Aug;17(4):405–414. doi: 10.1007/s11904-020-00508-z

Figure 1.

Figure 1.

Current and potential future targets for therapeutic interventions against chronic hepatitis delta virus infection.

Abbreviations: HDAg=hepatitis delta antigen; HDV=hepatitis delta virus; Host RNA pol=host RNA polymerase; HBsAg=hepatitis B surface antigen; L-HDAg=large hepatitis delta antigen; mRNA=messenger RNA; PEG-IFN-α=pegylated interferon alpha; S-HDAg=small hepatitis delta antigen

graphic file with name nihms-1608527-f0002.jpg